Pharmacological management for insomnia in children and adolescents with autism and attention deficit and hyperactivity disorder.

This review looks at sleep medications for children with autism and/or ADHD who have trouble sleeping. Sleep problems are very common in these children and can make their symptoms worse. While behavioral sleep strategies should be tried first, sometimes medication is needed. The review discusses various medication options including melatonin, antihistamines, and other prescription drugs that doctors might use to help these children sleep better.

This expert review examines pharmacological treatments for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD). The authors emphasize that untreated insomnia significantly worsens symptoms and quality of life in these populations. While behavioral interventions remain first-line treatment, pharmacological options are sometimes necessary. For ASD, off-label treatments include antihistamines, alpha-adrenergics, trazodone, antidepressants, antipsychotics, anticonvulsants, and hypnotics.

For ADHD, iron supplementation may help with restlessness when ferritin levels are low, while alpha2-adrenergics like guanfacine and clonidine provide sedative effects. The review recommends careful evaluation of comorbidities and existing medications before initiating treatment, with melatonin and behavioral strategies as preferred initial approaches.

Clinicians should prioritize behavioral interventions and melatonin before considering other pharmacological options. Careful evaluation of comorbidities and existing medications is essential. Multiple off-label options exist but require individualized assessment. Iron supplementation should be considered in ADHD patients with low ferritin levels.

This is a narrative review without systematic methodology. No sample size reported and evidence grading for individual interventions not provided. Limited detail on efficacy and safety data for specific medications mentioned.

Insomnia is common in children and adolescents with autism spectrum disorder (ASD) and/or attention deficit and hyperactivity disorder (ADHD), with significant implications for quality of life and prognosis. Although non-pharmacological interventions represent the first-line approach, they are not always effective. Therefore, it is important to determine when a pharmacological treatment can be indicated and which compound to prefer based on evidence of efficacy and safety. The literature evidence related to the pharmacological treatment of insomnia in ASD and/or ADHD is discussed.

We present data on drugs and supplements used and considerations about the choice of starting a pharmacological therapy, suggesting clinical advice that may guide clinicians. Untreated insomnia can worsen ASD and ADHD symptoms, impair cognitive function, and reduce quality of life. Targeted interventions are essential. Behavioral strategies, with or without melatonin, are recommended after evaluating comorbidities and medications.

Off-label treatments for children with ASD include antihistamines, alpha-adrenergics, trazodone, antidepressants, antipsychotics, anticonvulsants, and hypnotics. For ADHD, options include iron supplementation for restlessness and low ferritin levels, and alpha2-adrenergics like guanfacine and clonidine for their sedative effects.